- Home
- SLDP vs ABSI Comparison
SLDP vs ABSI Comparison
Compare SLDP & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLDP | ABSI |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | 157 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 993.3M | 577.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLDP | ABSI |
|---|---|---|
| Price | $4.93 | $3.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $7.78 |
| AVG Volume (30 Days) | ★ 8.4M | 4.4M |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,802,000.00 | $2,815,000.00 |
| Revenue This Year | $27.38 | $10.72 |
| Revenue Next Year | $36.18 | $437.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.85 | N/A |
| 52 Week Low | $0.68 | $2.01 |
| 52 Week High | $8.86 | $6.33 |
Technical Indicators
Market Signals| Indicator | SLDP | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 55.46 |
| Support Level | $4.80 | $3.36 |
| Resistance Level | $5.59 | $4.06 |
| Average True Range (ATR) | 0.32 | 0.26 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 19.63 | 68.22 |
Price Performance
Historical ComparisonAbout SLDP Solid Power Inc.
Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.